{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:34:54Z","timestamp":1774312494344,"version":"3.50.1"},"reference-count":39,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":523,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1111\/ijcp.12403","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T07:07:36Z","timestamp":1395904056000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"supplement s181","title":["A single-centre, open-label, prospective study of an initially short-term intensified dosing regimen of enteric-coated mycophenolate sodium with reduced cyclosporine A exposure in Chinese live-donor kidney transplant recipients"],"prefix":"10.1155","volume":"68","author":[{"given":"L.","family":"Cai","sequence":"first","affiliation":[{"name":"The Institute of Organ Transplantation; Tongji Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China"},{"name":"Key Laboratory of Ministry of Health and Key Laboratory of Ministry of Education; Wuhan China"},{"name":"Department of Otolaryngology-Head and Neck Surgery; Tongji Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Zeng","sequence":"additional","affiliation":[{"name":"The Institute of Organ Transplantation; Tongji Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China"},{"name":"Key Laboratory of Ministry of Health and Key Laboratory of Ministry of Education; Wuhan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Liu","sequence":"additional","affiliation":[{"name":"The Institute of Organ Transplantation; Tongji Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China"},{"name":"Key Laboratory of Ministry of Health and Key Laboratory of Ministry of Education; Wuhan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Wei","sequence":"additional","affiliation":[{"name":"The Institute of Organ Transplantation; Tongji Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China"},{"name":"Key Laboratory of Ministry of Health and Key Laboratory of Ministry of Education; Wuhan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Chen","sequence":"additional","affiliation":[{"name":"The Institute of Organ Transplantation; Tongji Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China"},{"name":"Key Laboratory of Ministry of Health and Key Laboratory of Ministry of Education; Wuhan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Institute of Organ Transplantation; Tongji Hospital; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China"},{"name":"Key Laboratory of Ministry of Health and Key Laboratory of Ministry of Education; Wuhan China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"10.1111\/ijcp.12403-BIB0001|ijcp12403-cit-0001","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0270-9295(03)00090-1","article-title":"Cyclosporine nephrotoxicity","volume":"23","author":"Burdmann","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1111\/ijcp.12403-BIB0002|ijcp12403-cit-0002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11906-002-0067-5","article-title":"Hypertensinogenic mechanism of the calcineurin inhibitors","volume":"4","author":"Curtis","year":"2002","journal-title":"Curr Hypertens Rep"},{"key":"10.1111\/ijcp.12403-BIB0003|ijcp12403-cit-0003","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0272-6386(12)81015-8","article-title":"Hypertension following kidney transplantation","volume":"23","author":"Curtis","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ijcp.12403-BIB0004|ijcp12403-cit-0004","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-199702150-00001","article-title":"Hyperlipidemia in solid transplantation","volume":"63","author":"Kobashigawa","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0005|ijcp12403-cit-0005","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ajh\/4.5.468","article-title":"Mechanism of cyclosporine induced hypertension","volume":"4","author":"Luke","year":"1991","journal-title":"Am J Hypertens"},{"key":"10.1111\/ijcp.12403-BIB0006|ijcp12403-cit-0006","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/ijcp.12403-BIB0007|ijcp12403-cit-0007","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0041-1345(00)02477-5","article-title":"A large, multicenter trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation","volume":"33","author":"Sperschneider","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1111\/ijcp.12403-BIB0008|ijcp12403-cit-0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.TP.0000100684.59784.FF","article-title":"Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy","volume":"77","author":"Gonzalez Molina","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0009|ijcp12403-cit-0009","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1600-6143.2004.00533.x","article-title":"Lower incidence of chronic allograft nephropathy at 1\u00a0year post-transplantation in patients treated with mycophenolate mofetil","volume":"4","author":"Merville","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/ijcp.12403-BIB0010|ijcp12403-cit-0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007890-199701150-00008","article-title":"Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups","volume":"63","author":"Halloran","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0011|ijcp12403-cit-0011","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/00007890-200105150-00017","article-title":"Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation","volume":"71","author":"Vincenti","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0012|ijcp12403-cit-0012","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00002018-200427070-00003","article-title":"Benefit-risk assessment of ciclosporin withdrawal in renal transplant recipients","volume":"27","author":"Thervet","year":"2004","journal-title":"Drug Saf"},{"key":"10.1111\/ijcp.12403-BIB0013|ijcp12403-cit-0013","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.tp.0000229424.11872.a0","article-title":"Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial","volume":"82","author":"Hazzan","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0014|ijcp12403-cit-0014","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1681\/ASN.2004100844","article-title":"Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study","volume":"16","author":"Abramowicz","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ijcp.12403-BIB0015|ijcp12403-cit-0015","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/01.TP.0000061606.64917.BE","article-title":"A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12\u00a0months after renal transplantation","volume":"75","author":"Pascual","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0016|ijcp12403-cit-0016","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1111\/j.1600-6143.2006.01535.x","article-title":"Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The \u2018reference\u2019 study","volume":"6","author":"Frimat","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ijcp.12403-BIB0017|ijcp12403-cit-0017","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/TP.0b013e318195a421","article-title":"Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis","volume":"87","author":"Moore","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0018|ijcp12403-cit-0018","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12403-BIB0019|ijcp12403-cit-0019","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1600-6143.2006.01645.x","article-title":"Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study","volume":"7","author":"Ekberg","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ijcp.12403-BIB0020|ijcp12403-cit-0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1399-0012.2004.00318.x","article-title":"Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared to mycophenolate mofetil","volume":"19","author":"Arns","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1111\/ijcp.12403-BIB0021|ijcp12403-cit-0021","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.tp.0000290678.06523.95","article-title":"Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients","volume":"84","author":"Bolin","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0022|ijcp12403-cit-0022","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/01.tp.0000209411.66790.b3","article-title":"Patient-reported gastrointestinal symptom burden and health-related quality of life following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium","volume":"81","author":"Chan","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0023|ijcp12403-cit-0023","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1432-2277.2009.00877.x","article-title":"Effect of conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium on maximum tolerated dose and gastrointestinal symptoms following kidney transplantation","volume":"22","author":"Shehata","year":"2009","journal-title":"Transpl Int"},{"key":"10.1111\/ijcp.12403-BIB0024|ijcp12403-cit-0024","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.transproceed.2009.06.067","article-title":"Use of mycophenolate sodium in stable renal transplant recipients in Spain: preliminary results of the MIDATA study","volume":"41","author":"S\u00e1nchez-Fructuoso","year":"2009","journal-title":"Transplant Proc"},{"issue":"Suppl. 3","key":"10.1111\/ijcp.12403-BIB0025|ijcp12403-cit-0025","first-page":"408","article-title":"Quality of life and tolerability of enteric-coated mycophenolate sodium (EC-MPS) in renal transplant recipients with gastrointestinal tract complaints to mycophenolate mofetil (MMF): a multicenter, randomized, open-label, controlled trial","volume":"9","author":"Ortega","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ijcp.12403-BIB0026|ijcp12403-cit-0026","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1016\/j.transproceed.2009.06.183","article-title":"Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium","volume":"41","author":"Bilodeau","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/ijcp.12403-BIB0027|ijcp12403-cit-0027","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.transproceed.2004.12.020","article-title":"Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients","volume":"37","author":"Massari","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/ijcp.12403-BIB0028|ijcp12403-cit-0028","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.tp.0000225760.09969.1f","article-title":"Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure","volume":"82","author":"Bunnapradist","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0029|ijcp12403-cit-0029","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/j.1600-6143.2007.01966.x","article-title":"A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients","volume":"7","author":"Takemoto","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ijcp.12403-BIB0030|ijcp12403-cit-0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1399-0012.2003.00026.x","article-title":"The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation","volume":"17","author":"Pelletier","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1111\/ijcp.12403-BIB0031|ijcp12403-cit-0031","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/ijcp.12403-BIB0032|ijcp12403-cit-0032","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1600-6143.2006.01291.x","article-title":"Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: a randomized, multicenter study","volume":"6","author":"Kamar","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ijcp.12403-BIB0033|ijcp12403-cit-0033","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2007.01983.x","article-title":"Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation","volume":"7","author":"Meur","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ijcp.12403-BIB0034|ijcp12403-cit-0034","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/ijcp.12403-BIB0035|ijcp12403-cit-0035","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/ijcp.12403-BIB0036|ijcp12403-cit-0036","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/TP.0b013e31816dd596","article-title":"Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients","volume":"85","author":"Gurk-Turner","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/ijcp.12403-BIB0037|ijcp12403-cit-0037","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.juro.2008.01.113","article-title":"Dual transplantation of marginal kidneys from nonheart beating donors selected using machine perfusion viability criteria","volume":"179","author":"Navarro","year":"2008","journal-title":"J Urol"},{"key":"10.1111\/ijcp.12403-BIB0038|ijcp12403-cit-0038","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1681\/ASN.V11101903","article-title":"Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids","volume":"11","author":"Tran","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ijcp.12403-BIB0039|ijcp12403-cit-0039","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.tp.0000225803.04995.2b","article-title":"Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients","volume":"82","author":"Asberg","year":"2006","journal-title":"Transplantation"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12403","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T02:50:30Z","timestamp":1648695030000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,27]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1111\/ijcp.12403","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,27]]},"assertion":[{"value":"2014-03-27","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}